http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107849007-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a06895fa4f8d1cbcff2dca217463f3fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_303bc59c36a116d3e6915c7de20dda1c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
filingDate 2016-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d08a273de017729481679cb36b34e3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_275d04e6ef150e3fbe7440e13f532a04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c1d657f23831ed5f9d3d102dbc2ef23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ea9c783a8da9a2867608a360051bbd
publicationDate 2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107849007-A
titleOfInvention Crystal form of bilastine and preparation method thereof
abstract The present invention relates to 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl) ethyl]-α,α-di New alpha and eta crystal forms of methyl-phenylacetic acid (bilastine). The present invention also relates to a method for its preparation, a pharmaceutical composition containing it, and its use in the treatment of histamine-mediated disease processes and allergic reactions.
priorityDate 2015-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03089425-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014026657-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-50032014-U1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103788062-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421272584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID185460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 45.